Swiss Re reports that Australian life insurers achieve a A$26.89 return for every A$1 spent on rehabilitation, but most claimants are referred after long delays.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
The upgrade to 'AA' reflects S&P's view that Sun Life will maintain strong capital support for its Hong Kong unit as it expands through agency, broker, and digital channels.
The FSU is demanding transparency on the full scale of planned job cuts at Acenda after three rounds of redundancies impacted 280 workers across departments.
